AUTL vs SPGI · rev $71.9M vs P/E 27, rev $15.34B
Autolus Therapeutics Ltd (AUTL) versus S&P Global Inc (SPGI) — a side-by-side from cached financials, not a winner call.
Autolus Therapeutics Ltd (AUTL) is a biotechnology company listed on US.
S&P Global Inc (SPGI) is a financial data & stock exchanges company listed on NYSE.
Latest reported AUTL revenue for 2026-06-30 was $71.9M. Net income was -$110.7M. AUTL currently screens at market cap $614.8M.
Latest reported SPGI revenue for 2025-12-31 was $15.34B. Net income was $4.47B. Revenue was up 7.9% from 2024-12-31 to 2025-12-31. SPGI currently screens at market cap $127.50B and trailing P/E 27.2.
AUTL currently screens at market cap $614.8M. SPGI currently screens at market cap $127.50B and trailing P/E 27.2.
Not investment advice. Open the AUTL and SPGI stock pages for the full models.
Not investment advice.